Eli Lilly and Company: The Floodgates To Growth Keep Opening, A Big Win In China

jetcityimage One of the most amazing growth stories, especially if you ignore the semiconductor space, over the past couple of years, has been pharmaceutical giant Eli Lilly and Company (NYSE:LLY). In just the past year, shares of the stock are up 88.5%. This comes on the back of tremendous growth driven by its weight loss drugs. As I detailed in a prior article, this has the potential to generate tremendous value for the company and its investors. But up until recently, the conversation has really only ...